Cash flow Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 10:05:55 16/01/2026 pm IST			5-day change	1st Jan Change
41.52 ^EUR	-1.38%		+6.78%	+12.17%

17/01	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
17/01	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE

7b7b903775a3cd.bV9fTQPaZyNGKt8zV0EJlESCnq6j-3LbMvX0s3qAqUI.XhZoL0uxNkd-e4BnZThopQbB_c3Ltie9Q5m1h0Ph2g48CDAYabAqRTAZmg

Published financial data: BAYER AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	4.14TCr	4.41TCr	5.07TCr	4.76TCr	4.66TCr
Total Revenues	4.14TCr	4.41TCr	5.07TCr	4.76TCr	4.66TCr
Cost of Goods Sold, Total	1.57TCr	1.7TCr	1.89TCr	1.97TCr	2.08TCr
Gross Profit	2.57TCr	2.7TCr	3.19TCr	2.79TCr	2.58TCr
Selling General & Admin Expenses, Total	1.39TCr	1.46TCr	1.6TCr	1.47TCr	1.68TCr
R&D Expenses	488.4Cr	532.6Cr	616.8Cr	583.5Cr	597.4Cr
Other Operating Expenses	2.8Cr	2.7Cr	53Cr	-46Cr	-13Cr
Other Operating Expenses, Total	1.88TCr	2TCr	2.27TCr	2.01TCr	2.26TCr
Operating Income	687.5Cr	707.1Cr	912.1Cr	779.9Cr	316.7Cr
Interest Expense, Total	-150Cr	-128.6Cr	-105.8Cr	-113.4Cr	-194.6Cr
Interest And Investment Income	20Cr	35Cr	38Cr	48Cr	52Cr
Net Interest Expenses	-129.8Cr	-94Cr	-68Cr	-65Cr	-142.5Cr
Income (Loss) On Equity Invest.	-9.6Cr	4.9Cr	-45Cr	-34Cr	-30Cr
Currency Exchange Gains (Loss)	-22Cr	-38Cr	-22Cr	-45Cr	-20Cr
Other Non Operating Income (Expenses)	10Cr	2.3Cr	-84Cr	-79Cr	146.3Cr
EBT, Excl. Unusual Items	536.7Cr	581.8Cr	692.9Cr	557.7Cr	270.7Cr
Restructuring Charges	-5.2Cr	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-223.8Cr	-	-73Cr	-669Cr	-326.3Cr
Gain (Loss) On Sale Of Investments	54Cr	-3.9Cr	-15Cr	-1.1Cr	-30L
Gain (Loss) On Sale Of Assets	3.4Cr	8.6Cr	-	-	-
Asset Writedown	9.2Cr	13Cr	169.1Cr	15Cr	16Cr
Insurance Settlements	-	-	-	-	-
Legal Settlements	-1.33TCr	-368.9Cr	-79Cr	-89Cr	-55Cr
Other Unusual Items	-766.4Cr	-26Cr	-227.5Cr	24Cr	-138.2Cr
EBT, Incl. Unusual Items	-1.72TCr	204.6Cr	467Cr	-162.1Cr	-233.4Cr
Income Tax Expense	-168.9Cr	102.4Cr	50Cr	132.1Cr	21Cr
Earnings From Continuing Operations	-1.56TCr	102.2Cr	416.6Cr	-294.2Cr	-254.6Cr
Earnings Of Discontinued Operations	507.4Cr	-	-	-	-
Net Income to Company	-1.05TCr	102.2Cr	416.6Cr	-294.2Cr	-254.6Cr
Minority Interest	-80L	-2.2Cr	-1.6Cr	10L	-60L
Net Income - (IS)	-1.05TCr	100Cr	415Cr	-294.1Cr	-255.2Cr
Net Income to Common Incl Extra Items	-1.05TCr	100Cr	415Cr	-294.1Cr	-255.2Cr
Net Income to Common Excl. Extra Items	-1.56TCr	100Cr	415Cr	-294.1Cr	-255.2Cr
Per Share Items
Net EPS - Basic	-10.68	1.02	4.22	-2.99	-2.6
Basic EPS - Continuing Operations	-15.85	1.02	4.22	-2.99	-2.6
Basic Weighted Average Shares Outstanding	98Cr	98Cr	98Cr	98Cr	98Cr
Net EPS - Diluted	-10.69	1.02	4.22	-2.99	-2.6
Diluted EPS - Continuing Operations	-15.85	1.02	4.22	-2.99	-2.6
Diluted Weighted Average Shares Outstanding	98Cr	98Cr	98Cr	98Cr	98Cr
Normalized Basic EPS	3.41	3.68	4.39	3.55	1.72
Normalized Diluted EPS	3.41	3.68	4.39	3.55	1.72
Dividend Per Share	2	2	2.4	0.11	0.11
Payout Ratio	-26.21	199.3	47.83	-80.89	-4.23
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	993.3Cr	834.2Cr	1.27TCr	1.13TCr	685.8Cr
EBITA	869.6Cr	718.8Cr	1.15TCr	1.01TCr	562.1Cr
EBIT	687.5Cr	707.1Cr	912.1Cr	779.9Cr	316.7Cr
EBITDAR	1.02TCr	862.8Cr	1.32TCr	1.18TCr	732.6Cr
Effective Tax Rate - (Ratio)	9.79	50.05	10.79	-81.49	-9.08
Current Domestic Taxes	72Cr	60Cr	91Cr	36Cr	5.8Cr
Current Foreign Taxes	57Cr	102.2Cr	165.9Cr	88Cr	89Cr
Total Current Taxes	128.7Cr	162.6Cr	257.1Cr	124.3Cr	94Cr
Total Deferred Taxes	-297.6Cr	-60Cr	-206.7Cr	7.8Cr	-73Cr
Normalized Net Income	334.64Cr	361.42Cr	431.46Cr	348.66Cr	168.59Cr
Interest Capitalized	3.4Cr	3Cr	3.8Cr	5.3Cr	6.1Cr
Interest on Long-Term Debt	-	-	-	7.2Cr	7.7Cr
Non-Cash Pension Expense	9.2Cr	6.2Cr	7.8Cr	12Cr	8.7Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.16TCr	1.23TCr	1.35TCr	1.26TCr	1.31TCr
General and Administrative Expenses	217Cr	225.7Cr	249Cr	214.2Cr	218.4Cr
Research And Development Expense From Footnotes	853.1Cr	572.1Cr	740.4Cr	563Cr	638.7Cr
Net Rental Expense, Total	27Cr	29Cr	45Cr	46Cr	47Cr
Imputed Operating Lease Interest Expense	8.23Cr	7.29Cr	9.5Cr	10Cr	18Cr
Imputed Operating Lease Depreciation	19Cr	21Cr	35Cr	36Cr	29Cr
Stock-Based Comp., Other (Total)	6.3Cr	24Cr	36Cr	15Cr	5.8Cr
Total Stock-Based Compensation	6.3Cr	24Cr	36Cr	15Cr	5.8Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	419.1Cr	456.4Cr	517.1Cr	590.7Cr	619.1Cr
Short Term Investments	131.1Cr	67Cr	3.2Cr	76Cr	7.5Cr
Trading Asset Securities, Total	638.1Cr	250.6Cr	495Cr	392.5Cr	182.1Cr
Total Cash And Short Term Investments	1.19TCr	773.9Cr	1.02TCr	1.06TCr	808.7Cr
Accounts Receivable, Total	955.6Cr	1.01TCr	1.03TCr	934.8Cr	897.3Cr
Other Receivables	258.7Cr	292.8Cr	313.3Cr	317.4Cr	321.5Cr
Notes Receivable	-	-	-	-	-
Total Receivables	1.21TCr	1.3TCr	1.34TCr	1.25TCr	1.22TCr
Inventory	1.1TCr	1.13TCr	1.36TCr	1.39TCr	1.35TCr
Other Current Assets, Total	67Cr	54Cr	52Cr	50Cr	70Cr
Total Current Assets	3.57TCr	3.26TCr	3.78TCr	3.76TCr	3.44TCr
Gross Property Plant And Equipment	2.36TCr	2.62TCr	2.83TCr	2.93TCr	3.12TCr
Accumulated Depreciation	-1.19TCr	-1.35TCr	-1.47TCr	-1.59TCr	-1.78TCr
Net Property Plant And Equipment	1.17TCr	1.27TCr	1.37TCr	1.33TCr	1.35TCr
Long-term Investments	199.8Cr	261.2Cr	289.5Cr	306Cr	302.2Cr
Goodwill	3.61TCr	4.01TCr	3.96TCr	3.23TCr	3TCr
Other Intangibles, Total	2.16TCr	2.2TCr	2.04TCr	1.98TCr	1.84TCr
Accounts Receivable Long-Term	10L	2.4Cr	2.4Cr	2.3Cr	2Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	468.6Cr	458Cr	560.5Cr	547.1Cr	616.4Cr
Deferred Charges Long-Term	441.8Cr	431.2Cr	379.7Cr	355.8Cr	371.8Cr
Other Long-Term Assets, Total	85Cr	138.3Cr	105.5Cr	114.9Cr	158.1Cr
Total Assets	12TCr	12TCr	12TCr	12TCr	11TCr
Liabilities
Accounts Payable, Total	568.3Cr	679.2Cr	754.5Cr	745.6Cr	751.8Cr
Accrued Expenses, Total	257.3Cr	350.5Cr	357.3Cr	249.5Cr	348.9Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	835.8Cr	415.5Cr	757.9Cr	653.6Cr	500.4Cr
Current Portion of Leases	21Cr	24Cr	28Cr	29Cr	31Cr
Current Income Taxes Payable	226.9Cr	69Cr	105.6Cr	62Cr	55Cr
Unearned Revenue Current, Total	362.8Cr	409.1Cr	419.8Cr	391.1Cr	368.4Cr
Other Current Liabilities	1.4TCr	993.8Cr	1.09TCr	814.6Cr	840.1Cr
Total Current Liabilities	3.67TCr	2.94TCr	3.51TCr	2.95TCr	2.9TCr
Long-Term Debt	3.23TCr	3.56TCr	3.28TCr	3.72TCr	3.46TCr
Long-Term Leases	92Cr	93Cr	95Cr	94Cr	94Cr
Unearned Revenue Non Current	74Cr	81Cr	60Cr	47Cr	34Cr
Pension & Other Post Retirement Benefits	845.4Cr	717.5Cr	438.8Cr	401.4Cr	331.2Cr
Deferred Tax Liability Non Current	133.1Cr	93Cr	73Cr	79Cr	86Cr
Other Non Current Liabilities	589.5Cr	1.23TCr	1.14TCr	1.03TCr	983.5Cr
Total Liabilities	8.63TCr	8.71TCr	8.6TCr	8.32TCr	7.88TCr
Common Stock, Total	251.5Cr	251.5Cr	251.5Cr	251.5Cr	251.5Cr
Retained Earnings	1.31TCr	1.33TCr	1.72TCr	1.22TCr	986.7Cr
Comprehensive Income and Other	1.5TCr	1.72TCr	1.9TCr	1.82TCr	1.95TCr
Total Common Equity	3.05TCr	3.3TCr	3.88TCr	3.29TCr	3.19TCr
Minority Interest	18Cr	15Cr	15Cr	15Cr	14Cr
Total Equity	3.07TCr	3.32TCr	3.89TCr	3.31TCr	3.2TCr
Total Liabilities And Equity	12TCr	12TCr	12TCr	12TCr	11TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	98Cr	98Cr	98Cr	98Cr	98Cr
ECS Total Common Shares Outstanding	98Cr	98Cr	98Cr	98Cr	98Cr
Book Value / Share	31.07	33.61	39.47	33.52	32.48
Tangible Book Value	-2.72TCr	-2.9TCr	-2.13TCr	-1.92TCr	-1.65TCr
Tangible Book Value Per Share	-27.68	-29.56	-21.67	-19.54	-16.83
Total Debt	4.18TCr	4.09TCr	4.17TCr	4.5TCr	4.08TCr
Net Debt	2.99TCr	3.31TCr	3.15TCr	3.44TCr	3.27TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	796.5Cr	625.6Cr	358.5Cr	306.1Cr	190.8Cr
Debt Equivalent Oper. Leases	216.8Cr	228.8Cr	357.6Cr	368.8Cr	374.4Cr
Minority Interest, Total (Incl. Fin. Div)	18Cr	15Cr	15Cr	15Cr	14Cr
Equity Method Investments, Total	49Cr	63Cr	89Cr	85Cr	82Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	265.2Cr	201.1Cr	269.5Cr	251.5Cr	208.1Cr
Inventories - Work In Process, Total	821Cr	916.4Cr	1.07TCr	1.13TCr	1.12TCr
Inventories - Others	9.9Cr	14Cr	22Cr	14Cr	15Cr
Land - (BS)	907.1Cr	982.7Cr	1.05TCr	1.07TCr	1.16TCr
Machinery, Total	1.2TCr	1.32TCr	1.46TCr	1.53TCr	1.66TCr
Full Time Employees	95.96T	95.95T	97.92T	96.93T	91.86T
Accumulated Allowance for Doubtful Accounts (Supple)	62Cr	65Cr	70Cr	64Cr	58Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-1.05TCr	100Cr	415Cr	-294.1Cr	-255.2Cr
Depreciation & Amortization - CF	162.3Cr	149.2Cr	154.5Cr	159.3Cr	159.5Cr
Amortization of Goodwill and Intangible Assets - (CF)	182.1Cr	12Cr	240.4Cr	231.6Cr	245.4Cr
Depreciation & Amortization, Total	344.4Cr	160.9Cr	394.9Cr	390.9Cr	404.9Cr
(Gain) Loss From Sale Of Asset	-13Cr	-22Cr	-169.2Cr	-15Cr	-21Cr
Asset Writedown & Restructuring Costs	981.5Cr	144.7Cr	255.4Cr	611.1Cr	473.4Cr
Net Cash From Discontinued Operations	33Cr	-	-	-	-
Other Operating Activities, Total	-673.7Cr	19Cr	83Cr	225.5Cr	125.9Cr
Change In Accounts Receivable	70Cr	-6.1Cr	27Cr	69Cr	20Cr
Change In Inventories	-90Cr	-17Cr	-217Cr	-43Cr	52Cr
Change In Accounts Payable	-35Cr	85Cr	61Cr	8.2Cr	-12Cr
Change in Other Net Operating Assets	922Cr	44Cr	-140.7Cr	-440.6Cr	-51Cr
Cash from Operations	490.3Cr	508.9Cr	709.3Cr	511.7Cr	736.8Cr
Capital Expenditure	-241.8Cr	-261.1Cr	-294.9Cr	-275.1Cr	-277.8Cr
Sale of Property, Plant, and Equipment	33Cr	37Cr	113Cr	22Cr	30Cr
Cash Acquisitions	-226.3Cr	-134Cr	-8.9Cr	-66Cr	-18Cr
Divestitures	417.2Cr	-60L	228.7Cr	80L	1.7Cr
Investment in Marketable and Equity Securities, Total	-402.7Cr	430.2Cr	-297.8Cr	-31Cr	232.5Cr
Other Investing Activities, Total	13Cr	14Cr	22Cr	-2.1Cr	49Cr
Cash from Investing	-407.3Cr	86Cr	-238.1Cr	-351.7Cr	16Cr
Long-Term Debt Issued, Total	1.09TCr	659.2Cr	663.1Cr	1.63TCr	581.5Cr
Total Debt Issued	1.09TCr	659.2Cr	663.1Cr	1.63TCr	581.5Cr
Long-Term Debt Repaid, Total	-642.4Cr	-904.4Cr	-760.5Cr	-1.3TCr	-1.08TCr
Total Debt Repaid	-642.4Cr	-904.4Cr	-760.5Cr	-1.3TCr	-1.08TCr
Issuance of Common Stock	-	-	-	2.3Cr	-
Repurchase of Common Stock	-	-	-1Cr	-2.4Cr	-1.6Cr
Common Dividends Paid	-275.1Cr	-199.3Cr	-198.5Cr	-237.9Cr	-11Cr
Common & Preferred Stock Dividends Paid	-275.1Cr	-199.3Cr	-198.5Cr	-237.9Cr	-11Cr
Other Financing Activities, Total	-129.3Cr	-120Cr	-125.1Cr	-155.2Cr	-203.6Cr
Cash from Financing	42Cr	-564.5Cr	-422Cr	-68Cr	-717.8Cr
Foreign Exchange Rate Adjustments	-24Cr	3.5Cr	11Cr	-18Cr	-6.8Cr
Miscellaneous Cash Flow Adjustments	-70L	3.9Cr	30L	-	-20L
Net Change in Cash	100.6Cr	37Cr	61Cr	74Cr	28Cr
Supplemental Items
Cash Interest Paid	130.1Cr	122.7Cr	129.6Cr	153.7Cr	197.7Cr
Cash Income Tax Paid (Refund)	106.3Cr	215.9Cr	203.4Cr	177Cr	122.2Cr
Levered Free Cash Flow	1.48TCr	-138.24Cr	584.74Cr	151.86Cr	371.61Cr
Unlevered Free Cash Flow	1.58TCr	-58Cr	650.86Cr	222.74Cr	493.24Cr
Change In Net Working Capital	-1.04TCr	423.4Cr	56Cr	395.8Cr	-162.4Cr
Net Debt Issued / Repaid	446.7Cr	-245.2Cr	-97Cr	325.3Cr	-501.8Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.53	3.73	4.65	4.04	1.74
Return on Total Capital	5.41	6.03	7.37	6.14	2.62
Return On Equity %	-39.83	3.2	11.56	-8.17	-7.82
Return on Common Equity	-40.03	3.15	11.56	-8.2	-7.87
Margin Analysis
Gross Profit Margin %	62.01	61.33	62.78	58.55	55.3
SG&A Margin	33.54	33.15	31.6	30.89	35.97
EBITDA Margin %	23.99	18.92	25.04	23.79	14.71
EBITA Margin %	21	16.31	22.71	21.23	12.06
EBIT Margin %	16.61	16.04	17.98	16.37	6.8
Income From Continuing Operations Margin %	-37.59	2.32	8.21	-6.18	-5.46
Net Income Margin %	-25.35	2.27	8.18	-6.17	-5.48
Net Avail. For Common Margin %	-37.61	2.27	8.18	-6.17	-5.48
Normalized Net Income Margin	8.08	8.2	8.5	7.32	3.62
Levered Free Cash Flow Margin	35.82	-3.14	11.52	3.19	7.97
Unlevered Free Cash Flow Margin	38.09	-1.31	12.83	4.68	10.58
Asset Turnover
Asset Turnover	0.34	0.37	0.41	0.4	0.41
Fixed Assets Turnover	3.42	3.61	3.85	3.53	3.48
Receivables Turnover (Average Receivables)	3.9	4.5	4.98	4.84	5.09
Inventory Turnover (Average Inventory)	1.46	1.53	1.51	1.43	1.52
Short Term Liquidity
Current Ratio	0.97	1.11	1.08	1.27	1.19
Quick Ratio	0.65	0.7	0.67	0.78	0.7
Operating Cash Flow to Current Liabilities	0.13	0.17	0.2	0.17	0.25
Days Sales Outstanding (Average Receivables)	93.86	81.17	73.26	75.34	71.94
Days Outstanding Inventory (Average Inventory)	251.47	238.5	241.1	254.93	240.83
Average Days Payable Outstanding	138.17	130.81	123.37	136.5	134.65
Cash Conversion Cycle (Average Days)	207.16	188.86	190.99	193.77	178.12
Long Term Solvency
Total Debt/Equity	136.05	123.23	107	136.06	127.36
Total Debt / Total Capital	57.64	55.2	51.69	57.64	56.02
LT Debt/Equity	108.13	109.99	86.81	115.41	110.78
Long-Term Debt / Total Capital	45.81	49.27	41.94	48.89	48.72
Total Liabilities / Total Assets	73.77	72.42	68.83	71.55	71.09
EBIT / Interest Expense	4.58	5.5	8.62	6.88	1.63
EBITDA / Interest Expense	6.88	6.75	12.35	10.32	3.71
(EBITDA - Capex) / Interest Expense	5.27	4.72	9.57	7.9	2.28
Total Debt / EBITDA	4.05	4.71	3.19	3.84	5.66
Net Debt / EBITDA	2.9	3.82	2.41	2.94	4.53
Total Debt / (EBITDA - Capex)	5.29	6.73	4.12	5.02	9.2
Net Debt / (EBITDA - Capex)	3.78	5.46	3.11	3.84	7.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.93	6.48	15.1	-6.11	-2.16
Gross Profit, 1 Yr. Growth %	-5.34	5.31	17.82	-12.44	-7.78
EBITDA, 1 Yr. Growth %	-8.11	-16.83	16.81	-10.81	-34.78
EBITA, 1 Yr. Growth %	-6.82	-18.25	19.33	-12.23	-39.55
EBIT, 1 Yr. Growth %	-1.5	1.42	22.02	-14.49	-54.65
Earnings From Cont. Operations, 1 Yr. Growth %	-745.68	-106.57	307.63	-170.62	-13.46
Net Income, 1 Yr. Growth %	-356.54	-109.53	315	-170.87	-13.23
Normalized Net Income, 1 Yr. Growth %	-7.2	6.08	12.09	-19.19	-58.93
Diluted EPS Before Extra, 1 Yr. Growth %	-750.76	-106.42	314.58	-170.94	-13.15
Accounts Receivable, 1 Yr. Growth %	-18.17	5.22	2.64	-9.39	-4.01
Inventory, 1 Yr. Growth %	2.92	3.22	20.52	2.28	-3.44
Net Property, Plant and Equip., 1 Yr. Growth %	-6.16	8.23	7.77	-2.58	1.01
Total Assets, 1 Yr. Growth %	-7.23	2.94	3.86	-6.9	-4.65
Tangible Book Value, 1 Yr. Growth %	27.82	7.71	-26.68	-9.86	-13.84
Common Equity, 1 Yr. Growth %	-35.4	8.18	17.42	-15.08	-3.09
Cash From Operations, 1 Yr. Growth %	-40.26	3.79	39.38	-27.86	43.99
Capital Expenditures, 1 Yr. Growth %	-8.75	7.98	12.95	-6.71	0.98
Levered Free Cash Flow, 1 Yr. Growth %	156.07	-109.27	377.87	-74.03	426.27
Unlevered Free Cash Flow, 1 Yr. Growth %	130.29	-103.65	260.61	-65.78	187.2
Dividend Per Share, 1 Yr. Growth %	-28.57	0	20	-95.42	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.15	0.61	10.71	3.96	-4.16
Gross Profit, 2 Yr. CAGR %	4.14	-0.16	11.39	1.57	-10.05
EBITDA, 2 Yr. CAGR %	17.91	-12.15	12.55	2.07	-26.53
EBITA, 2 Yr. CAGR %	21.98	-12.24	14.49	2.34	-30.16
EBIT, 2 Yr. CAGR %	27.08	0.65	14.38	2.14	-41.07
Earnings From Cont. Operations, 2 Yr. CAGR %	234.59	-34.88	-48.26	69.67	-21.82
Net Income, 2 Yr. CAGR %	148.83	-50.56	-37.12	71.49	-21.58
Normalized Net Income, 2 Yr. CAGR %	28.68	0.11	12.53	-4.83	-37.49
Diluted EPS Before Extra, 2 Yr. CAGR %	229.49	-35.35	-48.4	71.49	-21.51
Accounts Receivable, 2 Yr. CAGR %	-9.68	-7.22	3.92	-3.57	-6.74
Inventory, 2 Yr. CAGR %	-0.77	3.07	11.54	11.03	-0.62
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.88	0.83	8	2.46	-0.8
Total Assets, 2 Yr. CAGR %	-3.9	-2.38	3.4	-1.67	-5.78
Tangible Book Value, 2 Yr. CAGR %	6.55	16.84	-11.14	-18.71	-11.87
Common Equity, 2 Yr. CAGR %	-18.52	-16.41	12.71	-0.14	-9.28
Cash From Operations, 2 Yr. CAGR %	-21.3	-21.25	20.28	0.27	1.92
Capital Expenditures, 2 Yr. CAGR %	-3.43	-0.74	10.44	2.65	-2.94
Levered Free Cash Flow, 2 Yr. CAGR %	75.82	-51.15	-37.39	11.4	-20.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	66.71	-70.93	-35.93	11.09	-12.95
Dividend Per Share, 2 Yr. CAGR %	-15.48	-15.48	9.54	-76.55	-78.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.74	6.26	5.23	4.79	1.87
Gross Profit, 3 Yr. CAGR %	2.56	4.53	5.51	2.8	-1.58
EBITDA, 3 Yr. CAGR %	3.36	5.3	5.53	4.15	-14.25
EBITA, 3 Yr. CAGR %	2.4	7.14	7.29	4.78	-16.51
EBIT, 3 Yr. CAGR %	0	18.43	9.33	3.81	-24.89
Earnings From Cont. Operations, 3 Yr. CAGR %	68.58	-9.74	20.01	-42.61	35.56
Net Income, 3 Yr. CAGR %	12.68	-16.13	0.48	-34.56	36.66
Normalized Net Income, 3 Yr. CAGR %	-3.41	21.38	6.16	0.77	-24.06
Diluted EPS Before Extra, 3 Yr. CAGR %	62.04	-11.33	20.11	-42.62	36.7
Accounts Receivable, 3 Yr. CAGR %	3.64	-4.97	-4.05	-0.72	-3.71
Inventory, 3 Yr. CAGR %	18.72	0.54	8.59	8.36	5.98
Net Property, Plant and Equip., 3 Yr. CAGR %	15.33	-0.66	3.1	4.35	1.98
Total Assets, 3 Yr. CAGR %	15.95	-1.74	-0.34	-0.16	-2.67
Tangible Book Value, 3 Yr. CAGR %	34	6.63	0.03	-10.71	-17.12
Common Equity, 3 Yr. CAGR %	-6.04	-10.45	-6.38	2.56	-1.14
Cash From Operations, 3 Yr. CAGR %	-15.53	-13.7	-4.75	1.43	13.13
Capital Expenditures, 3 Yr. CAGR %	0.73	0.23	3.63	4.39	2.09
Levered Free Cash Flow, 3 Yr. CAGR %	50.09	-33.95	0.32	-53.31	44.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	48.5	-53.28	-1.68	-48.02	39.81
Dividend Per Share, 3 Yr. CAGR %	-10.61	-10.61	-5.01	-61.97	-61.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.12	4.76	7.7	5.33	1.37
Gross Profit, 5 Yr. CAGR %	0.15	2.76	6.01	3.33	-1.01
EBITDA, 5 Yr. CAGR %	0.11	-1.32	7.15	9.66	-8.7
EBITA, 5 Yr. CAGR %	0.55	-2.3	7.31	11.6	-9.64
EBIT, 5 Yr. CAGR %	0.3	1.52	5.82	12.87	-14.62
Earnings From Cont. Operations, 5 Yr. CAGR %	31.13	-22.92	5.1	16.18	1.1
Net Income, 5 Yr. CAGR %	20.62	-26.08	-10.77	11.65	-9.01
Normalized Net Income, 5 Yr. CAGR %	-2.39	-0.07	3.05	11.53	-14.11
Diluted EPS Before Extra, 5 Yr. CAGR %	26.63	-25.7	2.52	15.44	1.32
Accounts Receivable, 5 Yr. CAGR %	-0.77	-1.73	3.75	-4.41	-5.13
Inventory, 5 Yr. CAGR %	5.09	6.12	15.79	4.61	4.81
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.1	-0.66	12.37	0.58	1.52
Total Assets, 5 Yr. CAGR %	9.63	7.89	10.71	-1.71	-2.56
Tangible Book Value, 5 Yr. CAGR %	34.03	92.25	13.5	-4.33	-4.92
Common Equity, 5 Yr. CAGR %	4.7	1.71	1.05	-6.46	-7.55
Cash From Operations, 5 Yr. CAGR %	-6.58	-10.95	-2.7	-8.36	-2.13
Capital Expenditures, 5 Yr. CAGR %	-0.8	0.25	4.5	1.19	0.95
Levered Free Cash Flow, 5 Yr. CAGR %	26.97	-5.13	5.92	-20.55	-8.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	25.92	-23.5	6.21	-17.06	-6.35
Dividend Per Share, 5 Yr. CAGR %	-4.36	-5.83	-3.04	-47.66	-47.66